Key result
AAV9 viral vector delivery of Sfrp1 attenuated TAC-induced cardiac dysfunction and improved systolic and diastolic functions by inhibiting Wnt signaling pathway-mediated apoptosis in mice.
Why the study?
Does AAV9-mediated Sfrp1 gene delivery improve cardiac function and reduce apoptosis in mice with TAC-induced heart failure?
Does AAV9-mediated Sfrp1 gene delivery improve cardiac function and reduce apoptosis in mice with TAC-induced heart failure?
Answers are grounded in this paper and cite their sources.
Sfrp1 gene delivery via AAV9 vector attenuates TAC-induced cardiac dysfunction in mice by inhibiting Wnt signaling-mediated apoptosis.
BACKGROUND: Hemodynamic overload causes cardiac hypertrophy leading to heart failure. Wnt signaling pathway was reported activated in heart failure. Secreted frizzled related protein 1 (Sfrp1) is a suppressor of Wnt signaling activation. The aim of the present study was to investigate the protective effect of Sfrp1 on hemodynamic overload- induced cardiac dysfunction. METHODS: A mice transverse aortic constriction (TAC)- induced heart failure model was established. A recombinant adeno-associated virus 9 (AAV9) vector was used to deliver Sfrp1 gene into myocardium. Fluorescence and immunohistochemistry staining was used to evaluate the effectiveness of viral vector delivery. Invasive hemodynamic examination was used to evaluate cardiac systolic and diastolic functions. Myocardium apoptosis was detected by TUNEL assay. The expression levels of Sfrp1, β-catenin, caspase3, Bax, Bcl-2 and c-Myc were measured by Western blotting. RESULTS: Increased mean arterial pressure and impaired cardiac function confirmed the establishment of TAC model. Sfrp1 protein expression was effectively increased in myocardium of mice treated with AAV9-Sfrp1 viral vector. The viral vector administration improved both systolic and diastolic cardiac functions by reducing myocardial apoptosis in TAC mice. The expression levels of β-catenin, caspase3 and Bax were significantly reduced while the expression levels of Bcl-2 and c-Myc were dramatically increased in myocardium by the viral vector treatment in TAC mice. CONCLUSIONS: AAV9 viral vector delivered sfrp1 expression gene into myocardium, which attenuated TAC-induced cardiac dysfunction by inhibiting Wnt signaling pathway activation- mediated apoptosis.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2018) studied Hemodynamic overload-induced cardiac dysfunction. AAV9-Sfrp1 viral vector was evaluated on Cardiac systolic and diastolic functions and myocardial apoptosis. AAV9 viral vector delivery of Sfrp1 attenuated TAC-induced cardiac dysfunction and improved systolic and diastolic functions by inhibiting Wnt signaling pathway-mediated apoptosis in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: